Trial Profile
Levetiracetam for Neuroprotection Against Corticosteroid-Induced Hippocampal Dysfunction: A Proof of Concept Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Oct 2014
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Cognition disorders; Mania
- Focus Proof of concept; Therapeutic Use
- 02 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Oct 2009 New trial record